The emergence of SARS-CoV-2 variants of concern (VOCs) and variants of interest (VOIs)
with decreased susceptibility to neutralization has generated interest in assessments of …

Variant SARS-CoV-2 and the mRNA-1273 Vaccine How well do serum samples from persons
vaccinated with the mRNA-1273 vaccine neutralize the P.1 lineage, the B.1.1.7 lineage, …

The staggering array of nanotechnological products, found in our environment and those
applicable in medicine, has stimulated a growing interest in examining their long-term impact …

The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in 2019
has triggered an ongoing global pandemic of the severe pneumonia-like disease …

Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is the causative infection
of a global pandemic that has led to more than 2 million deaths worldwide. The Moderna …

INTRODUCTION Mass vaccination against severe acute respiratory syndrome coronavirus
2 (SARS-CoV-2) offers the most efficient public health intervention to control the COVID-19 …

Background Neuroblastoma, a frequently occurring solid tumour in children, remains a
therapeutic challenge as existing imaging tools are inadequate for proper and accurate diagnosis…

Pathogenic H7N9 avian influenza viruses continue to represent a public health concern, and
several candidate vaccines are currently being developed. It is vital to assess if protective …

Neutralizing antibody responses gradually wane against several variants of concern (VOCs)
after vaccination with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) …

The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants
has led to growing concerns over increased transmissibility and the ability of some variants …